On Monday, three committees in Mexico’s senate — constitutional issues, energy and legislative studies — voted to bring an energy reform bill to the chamber’s floor for debate. The legislation would provide international oil companies the opportunity to participate in profit-sharing contracts and concession-like licenses for energy operations in Mexico, and it is expected to become law by the end of the legislative session Dec. 15.
Founding director Ambassador Edward P. Djerejian has joined eight former U.S. ambassadors to Israel and former under secretaries of state in urging Congress to support the interim agreement on Iran’s nuclear program.
Leading U.S. immigration experts, public policy scholars and political figures debate issues and solutions to crucial questions surrounding comprehensive immigration reform.
The United States should assign a particularly high priority on science and technology over the next four years, especially for federal support of research.
The NIH, which has an annual budget of over US$31 billion, is the world’s largest biomedical research agency and is a major strength for science in the U.S. Despite the political nature of stem cell research, this area of science has flourished across the country. In 2010, the NIH funded approximately US$1.3 billion in stem cell research. According to the ISI Web of Science, more than 4,000 U.S.-authored stem cell publications were produced in 2010 — approximately 40% of the world total. The average citation rate was 4.12 per article, with six articles amassing 100 citations in less than 18 months after release.
